Skip to main content
Top
Published in: Rheumatology International 9/2012

01-09-2012 | Original Article

Down-regulation of adiponectin in patients with familial Mediterranean fever during attack-free period

Authors: Vedat Gerdan, Ismail Sari, Didem Kozacı, Fatos Onen, Feride Yüksel, Özgül Soysal, Dilek Solmaz, Necati Günay, Nurullah Akkoc, Servet Akar

Published in: Rheumatology International | Issue 9/2012

Login to get access

Abstract

To evaluate the circulating levels of adipokines (leptin and adiponectin) and ghrelin in patients with familial Mediterranean fever (FMF) and also to assess the relationships between these molecules and disease-related parameters. Forty-eight FMF patients in attack-free period (31 men, [M], 17 women, [F], mean age 35.8 ± 8.6 years, and a mean body mass index [BMI] of 24.7 ± 3.1) and 40 age-, sex-, and BMI-matched healthy controls (24 M, 16 F, mean age 35.5 ± 8.5 years, and a mean BMI of 24.5 ± 2.8) were included in the study. Patients and controls with a history of any other chronic diseases and obese or underweight subjects were excluded. High-sensitive C-reactive protein (hs-CRP), leptin, adiponectin, and total ghrelin concentrations were studied. Age, sex, BMI, waist circumference, and smoking status were similar between FMF patients and controls (P > 0.05). Adipose tissue-derived molecules including leptin, and adiponectin were lower than healthy controls but only adiponectin levels reached the statistically significance (16.7 ± 8.9 ng/ml vs. 27.7 ± 15.9 ng/ml, P < 0.001) and leptin concentrations just missed significance (25.2 ± 16.2 ng/ml vs. 34.9 ± 27.2 ng/ml, P = 0.051). Ghrelin concentrations were not different between the groups. Adiponectin levels were significantly and negatively correlated with hs-CRP (P < 0.05, r = −0.24). The results of this study suggest that low-grade chronic inflammation during attack-free period in FMF patients may suppress adiponectin production or low levels of adiponectin might contribute to subclinical inflammation in these patients.
Literature
2.
go back to reference Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45(6):746–750CrossRef Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45(6):746–750CrossRef
3.
go back to reference Tunca M, Kirkali G, Soyturk M, Akar S, Pepys MB, Hawkins PN (1999) Acute phase response and evolution of familial mediterranean fever. Lancet 353(9162):1415PubMedCrossRef Tunca M, Kirkali G, Soyturk M, Akar S, Pepys MB, Hawkins PN (1999) Acute phase response and evolution of familial mediterranean fever. Lancet 353(9162):1415PubMedCrossRef
4.
go back to reference Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115(5):911–919 quiz 20PubMedCrossRef Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115(5):911–919 quiz 20PubMedCrossRef
5.
go back to reference Schaffler A, Scholmerich J (2010) Innate immunity and adipose tissue biology. Trends Immunol 31(6):228–235PubMedCrossRef Schaffler A, Scholmerich J (2010) Innate immunity and adipose tissue biology. Trends Immunol 31(6):228–235PubMedCrossRef
6.
go back to reference Ueno H, Shiiya T, Nakazato M (2010) Translational research of ghrelin. Ann NY Acad Sci 1200:120–127PubMedCrossRef Ueno H, Shiiya T, Nakazato M (2010) Translational research of ghrelin. Ann NY Acad Sci 1200:120–127PubMedCrossRef
7.
go back to reference Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885PubMedCrossRef Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885PubMedCrossRef
8.
go back to reference Ouchi N, Walsh K (2007) Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380(1–2):24–30PubMedCrossRef Ouchi N, Walsh K (2007) Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380(1–2):24–30PubMedCrossRef
9.
go back to reference Yokota T, Meka CS, Kouro T, Medina KL, Igarashi H, Takahashi M et al (2003) Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol 171(10):5091–5099PubMed Yokota T, Meka CS, Kouro T, Medina KL, Igarashi H, Takahashi M et al (2003) Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol 171(10):5091–5099PubMed
10.
go back to reference Schaffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Scholmerich J et al (2003) Adipocytokines in synovial fluid. JAMA 290(13):1709–1710PubMedCrossRef Schaffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Scholmerich J et al (2003) Adipocytokines in synovial fluid. JAMA 290(13):1709–1710PubMedCrossRef
11.
go back to reference Laurberg TB, Frystyk J, Ellingsen T, Hansen IT, Jorgensen A, Tarp U et al (2009) Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. J Rheumatol 36(9):1885–1891PubMedCrossRef Laurberg TB, Frystyk J, Ellingsen T, Hansen IT, Jorgensen A, Tarp U et al (2009) Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. J Rheumatol 36(9):1885–1891PubMedCrossRef
12.
go back to reference Sada KE, Yamasaki Y, Maruyama M, Sugiyama H, Yamamura M, Maeshima Y et al (2006) Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33(8):1545–1552PubMed Sada KE, Yamasaki Y, Maruyama M, Sugiyama H, Yamamura M, Maeshima Y et al (2006) Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33(8):1545–1552PubMed
13.
go back to reference Oguz Y, Yilmaz MI, Acikel C, Eyileten T, Caglar K, Oktenli C et al (2009) The relationship between adiponectin levels and degree of proteinuria in patients with nephrotic and non-nephrotic proteinuria. Ren Fail 31(1):29–35PubMedCrossRef Oguz Y, Yilmaz MI, Acikel C, Eyileten T, Caglar K, Oktenli C et al (2009) The relationship between adiponectin levels and degree of proteinuria in patients with nephrotic and non-nephrotic proteinuria. Ren Fail 31(1):29–35PubMedCrossRef
14.
go back to reference Toussirot E, Streit G, Nguyen NU, Dumoulin G, Le Huede G, Saas P et al (2007) Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism 56(10):1383–1389PubMedCrossRef Toussirot E, Streit G, Nguyen NU, Dumoulin G, Le Huede G, Saas P et al (2007) Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism 56(10):1383–1389PubMedCrossRef
15.
go back to reference Takeshita S, Takabayashi H, Yoshida N (2006) Circulating adiponectin levels in kawasaki disease. Acta Paediatr 95(10):1312–1314PubMedCrossRef Takeshita S, Takabayashi H, Yoshida N (2006) Circulating adiponectin levels in kawasaki disease. Acta Paediatr 95(10):1312–1314PubMedCrossRef
16.
go back to reference Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B (2007) Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 92(2):571–576PubMedCrossRef Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B (2007) Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 92(2):571–576PubMedCrossRef
17.
go back to reference Fantuzzi G (2008) Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 121(2):326–330PubMedCrossRef Fantuzzi G (2008) Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 121(2):326–330PubMedCrossRef
18.
go back to reference Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M et al (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107(5):671–674PubMedCrossRef Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M et al (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107(5):671–674PubMedCrossRef
19.
go back to reference Cansu B, Cansu DU, Kasifoglu T, Gulbas Z, Korkmaz C (2011) Disease-modifying antirheumatic drugs increase serum adiponectin levels in patients with rheumatoid arthritis. J Clin Rheumatol 17(1):14–17PubMed Cansu B, Cansu DU, Kasifoglu T, Gulbas Z, Korkmaz C (2011) Disease-modifying antirheumatic drugs increase serum adiponectin levels in patients with rheumatoid arthritis. J Clin Rheumatol 17(1):14–17PubMed
20.
go back to reference Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF (2010) Adiponectin action from head to toe. Endocrine 37(1):11–32PubMedCrossRef Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF (2010) Adiponectin action from head to toe. Endocrine 37(1):11–32PubMedCrossRef
21.
go back to reference Keskin G, Inal A, Ozisik L (2010) Serum adiponectin levels in patients with familial mediterranean fever. Protein Pept Lett 17(10):1258–1262PubMedCrossRef Keskin G, Inal A, Ozisik L (2010) Serum adiponectin levels in patients with familial mediterranean fever. Protein Pept Lett 17(10):1258–1262PubMedCrossRef
22.
go back to reference Matarese G, Moschos S, Mantzoros CS (2005) Leptin in immunology. J Immunol 174(6):3137–3142PubMed Matarese G, Moschos S, Mantzoros CS (2005) Leptin in immunology. J Immunol 174(6):3137–3142PubMed
23.
go back to reference Sari I, Demir T, Kozaci LD, Akar S, Kavak T, Birlik M et al (2007) Body composition, insulin, and leptin levels in patients with ankylosing spondylitis. Clin Rheumatol 26(9):1427–1432PubMedCrossRef Sari I, Demir T, Kozaci LD, Akar S, Kavak T, Birlik M et al (2007) Body composition, insulin, and leptin levels in patients with ankylosing spondylitis. Clin Rheumatol 26(9):1427–1432PubMedCrossRef
24.
go back to reference Neumann E, Frommer KW, Vasile M, Müller-Ladner U (2011) Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? Arthritis Rheum 63(5):1159–1169 Neumann E, Frommer KW, Vasile M, Müller-Ladner U (2011) Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? Arthritis Rheum 63(5):1159–1169
25.
go back to reference Toy B, Tarcin O, Bagci S, Ustundag Y, Inal A, Tiftikci A (2006) Serum leptin is not a diagnostic marker for familial Mediterranean fever attacks. Mediat Inflamm 2006(2):62868 Toy B, Tarcin O, Bagci S, Ustundag Y, Inal A, Tiftikci A (2006) Serum leptin is not a diagnostic marker for familial Mediterranean fever attacks. Mediat Inflamm 2006(2):62868
26.
go back to reference Yuksel S, Samli H, Colbay M, Dundar U, Acarturk G, Demir S et al (2009) Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial mediterranean fever. Tohoku J Exp Med 217(4):321–327PubMedCrossRef Yuksel S, Samli H, Colbay M, Dundar U, Acarturk G, Demir S et al (2009) Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial mediterranean fever. Tohoku J Exp Med 217(4):321–327PubMedCrossRef
27.
go back to reference Theil MM, Miyake S, Mizuno M, Tomi C, Croxford JL, Hosoda H et al (2009) Suppression of experimental autoimmune encephalomyelitis by ghrelin. J Immunol 183(4):2859–2866PubMedCrossRef Theil MM, Miyake S, Mizuno M, Tomi C, Croxford JL, Hosoda H et al (2009) Suppression of experimental autoimmune encephalomyelitis by ghrelin. J Immunol 183(4):2859–2866PubMedCrossRef
28.
go back to reference Otero M, Nogueiras R, Lago F, Dieguez C, Gomez-Reino JJ, Gualillo O (2004) Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology (Oxford) 43(3):306–310CrossRef Otero M, Nogueiras R, Lago F, Dieguez C, Gomez-Reino JJ, Gualillo O (2004) Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology (Oxford) 43(3):306–310CrossRef
29.
go back to reference Kim HA, Choi GS, Jeon JY, Yoon JM, Sung JM, Suh CH (2010) Leptin and ghrelin in Korean systemic lupus erythematosus. Lupus 19(2):170–174PubMedCrossRef Kim HA, Choi GS, Jeon JY, Yoon JM, Sung JM, Suh CH (2010) Leptin and ghrelin in Korean systemic lupus erythematosus. Lupus 19(2):170–174PubMedCrossRef
30.
go back to reference De Sanctis JB, Zabaleta M, Bianco NE, Garmendia JV, Rivas L (2009) Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 42(4):272–274PubMedCrossRef De Sanctis JB, Zabaleta M, Bianco NE, Garmendia JV, Rivas L (2009) Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 42(4):272–274PubMedCrossRef
31.
go back to reference Toussirot E, Gaugler B, Bouhaddi M, Nguyen NU, Saas P, Dumoulin G (2010) Elevated adiponectin serum levels in women with systemic autoimmune diseases. Mediators Inflamm 2010:938408 Toussirot E, Gaugler B, Bouhaddi M, Nguyen NU, Saas P, Dumoulin G (2010) Elevated adiponectin serum levels in women with systemic autoimmune diseases. Mediators Inflamm 2010:938408
32.
go back to reference Keskin G, Inal A, Ilikci R, Baysal O (2009) Plasma ghrelin levels in patients with familial mediterranean fever. Protein Pept Lett 16(7):830–833PubMedCrossRef Keskin G, Inal A, Ilikci R, Baysal O (2009) Plasma ghrelin levels in patients with familial mediterranean fever. Protein Pept Lett 16(7):830–833PubMedCrossRef
33.
go back to reference Koca SS, Ozgen M, Aydin S, Dag S, Evren B, Isik A (2008) Ghrelin and obestatin levels in rheumatoid arthritis. Inflammation 31(5):329–335PubMedCrossRef Koca SS, Ozgen M, Aydin S, Dag S, Evren B, Isik A (2008) Ghrelin and obestatin levels in rheumatoid arthritis. Inflammation 31(5):329–335PubMedCrossRef
34.
go back to reference Broglio F, Prodam F, Me E, Riganti F, Lucatello B, Granata R et al (2005) Ghrelin: endocrine, metabolic and cardiovascular actions. J Endocrinol Invest 28(5 Suppl):23–25 Research Support, Non-US Gov’t ReviewPubMed Broglio F, Prodam F, Me E, Riganti F, Lucatello B, Granata R et al (2005) Ghrelin: endocrine, metabolic and cardiovascular actions. J Endocrinol Invest 28(5 Suppl):23–25 Research Support, Non-US Gov’t ReviewPubMed
Metadata
Title
Down-regulation of adiponectin in patients with familial Mediterranean fever during attack-free period
Authors
Vedat Gerdan
Ismail Sari
Didem Kozacı
Fatos Onen
Feride Yüksel
Özgül Soysal
Dilek Solmaz
Necati Günay
Nurullah Akkoc
Servet Akar
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2094-5

Other articles of this Issue 9/2012

Rheumatology International 9/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.